Paper · 20056790
High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia.
Smith AC and 12 others. Blood, 2010. Cited by 103 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia. Papers, record 20056790. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20056790
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Disease Models, Animal | Major topic |
| Neoplasm Transplantation | Major topic |
| Neoplastic Stem Cells | Major topic |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Zebrafish | Major topic |
| Animals | |
| Animals, Genetically Modified | |
| Cell Separation | |
| Flow Cytometry | |
| Image Processing, Computer-Assisted | |
| Microscopy, Fluorescence |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 5 R01 CA103846-04 | NCI NIH HHS | United States | R01CA103846 | PubMed and NIH | NIH RePORTER |
| T32 GM007753 | NIGMS NIH HHS | United States | T32GM007753 | PubMed and NIH | NIH RePORTER |
| R01 CA103846 | NCI NIH HHS | United States | R01CA103846 | PubMed and NIH | NIH RePORTER |
| 3 K01 AR055619-03S1 | NIAMS NIH HHS | United States | K01AR055619 | PubMed and NIH | NIH RePORTER |
| K01 AR055619-01A1 | NIAMS NIH HHS | United States | K01AR055619 | PubMed and NIH | NIH RePORTER |
| K01 AR055619 | NIAMS NIH HHS | United States | K01AR055619 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15,472,075 | Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. | Science | 2004 | https://conductscience.org/library/papers/15472075 | PubMed |
| 2 | 17,114,293 | NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/17114293 | PubMed |
| 3 | 19,516,274 | Heritable T-cell malignancy models established in a zebrafish phenotypic screen. | Leukemia | 2009 | https://conductscience.org/library/papers/19516274 | PubMed |
| 4 | 17,510,286 | Effects of RAS on the genesis of embryonal rhabdomyosarcoma. | Genes Dev | 2007 | https://conductscience.org/library/papers/17510286 | PubMed |
| 5 | 14,582,078 | Gene expression profiling in T-cell acute lymphoblastic leukemia. | Semin Hematol | 2003 | https://conductscience.org/library/papers/14582078 | PubMed |
| 6 | 18,345,029 | Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic Zebrafish. | Oncogene | 2008 | https://conductscience.org/library/papers/18345029 | PubMed |
| 7 | 17,641,192 | Tumor growth need not be driven by rare cancer stem cells. | Science | 2007 | https://conductscience.org/library/papers/17641192 | PubMed |
| 8 | 16,540,662 | Transplantable tumor lines generated in clonal zebrafish. | Cancer Res | 2006 | https://conductscience.org/library/papers/16540662 | PubMed |
| 9 | 15,142,873 | Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation. | Blood | 2004 | https://conductscience.org/library/papers/15142873 | PubMed |
| 10 | 18,372,910 | Catch of the day: zebrafish as a human cancer model. | Oncogene | 2008 | https://conductscience.org/library/papers/18372910 | PubMed |
1 to 10 of 28
See all 28 referencesCited by81
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 103 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,879,028 | Using Zebrafish Larvae as a Xenotransplantation Model to Study Ewing Sarcoma. | Methods Mol Biol | 2027 | https://conductscience.org/library/papers/42879028 | PubMed |
| 42,802,717 | Zebrafish against cancer: towards clinical relevance. | Dis Model Mech | 2026 | https://conductscience.org/library/papers/42802717 | PubMed |
| 42,699,572 | MAPK-driven MYC/p21 axis controls senescence bypass and BCL-XL dependence in vincristine-resistant rhabdomyosarcoma. | iScience | 2026 | https://conductscience.org/library/papers/42699572 | PubMed |
| 39,216,481 | A conserved transcription factor regulatory program promotes tendon fate. | Dev Cell | 2024 | https://conductscience.org/library/papers/39216481 | PubMed |
| 39,052,000 | A syngeneic spontaneous zebrafish model of tp53-deficient, EGFRvIII, and PI3KCAH1047R-driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapse in vivo. | Elife | 2024 | https://conductscience.org/library/papers/39052000 | PubMed |
| 38,656,392 | Dynamic Changes in Lymphocyte Populations Establish Zebrafish as a Thymic Involution Model. | J Immunol | 2024 | https://conductscience.org/library/papers/38656392 | PubMed |
| 38,104,416 | Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia. | Biomed Pharmacother | 2024 | https://conductscience.org/library/papers/38104416 | PubMed |
| 37,188,201 | Tumor heterogeneity: preclinical models, emerging technologies, and future applications. | Front Oncol | 2023 | https://conductscience.org/library/papers/37188201 | PubMed |
| 37,179,373 | Immune gene variation associated with chromosome-scale differences among individual zebrafish genomes. | Sci Rep | 2023 | https://conductscience.org/library/papers/37179373 | PubMed |
| 36,428,753 | Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia? | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36428753 | PubMed |
1 to 10 of 81
See all 81 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20056790
GET https://conductscience.org/api/papers/v1/20056790/references?page=2